Long-term medical-care costs related to prostate cancer: Estimates from linked SEER-Medicare data

M. E. Stokes, L. Black, Á Benedict, Claus Roehrborn, P. Albertsen

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

Limited data are available concerning long-term prostate cancer (PCa)-related medical costs for use in assessing PCa prevention strategies. The aim of this study was to examine treatment, long-term survival, and long-term PCa-related costs by cancer stage. Costs in phases of care based on the natural history of PCa were also examined. Our data illustrate that initial care is characteristic of a rapid rate of cost accrual. This rate then decreases during continuing care. For terminal care, only stage IV resumes a rate of cost accrual similar to initial care. With average PCa-related costs of $18 168 observed over an average follow-up of 4 years, prevention strategies may result in a reduction in medical costs.

Original languageEnglish (US)
Pages (from-to)278-284
Number of pages7
JournalProstate Cancer and Prostatic Diseases
Volume13
Issue number3
DOIs
StatePublished - Sep 2010

Keywords

  • Health-care costs
  • Prostate cancer
  • Survival
  • Utilization

ASJC Scopus subject areas

  • Oncology
  • Urology
  • Cancer Research

Fingerprint Dive into the research topics of 'Long-term medical-care costs related to prostate cancer: Estimates from linked SEER-Medicare data'. Together they form a unique fingerprint.

Cite this